Paggiarino Dario A.

Related Filers (2)

Ownership (38)

4
Tuesday, 2/13/2024
EyePoint Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 1/30/2024
EyePoint Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 1/29/2024
EyePoint Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 1/25/2024
EyePoint Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 1/10/2024
EyePoint Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 1/9/2024
EyePoint Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 12/15/2023
EyePoint Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 12/6/2023
EyePoint Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 6/22/2023
EyePoint Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 2/13/2023
EyePoint Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 1/10/2023
EyePoint Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 3/2/2022
EyePoint Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 2/11/2022
EyePoint Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 6/23/2021
EyePoint Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 6/15/2021
EyePoint Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 3/2/2021
EyePoint Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 7/2/2020
EyePoint Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 6/30/2020
EyePoint Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 6/16/2020
EyePoint Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 3/3/2020
EyePoint Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 10/15/2019
EyePoint Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 6/28/2019
EyePoint Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 6/27/2019
EyePoint Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 6/17/2019
EyePoint Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 3/21/2019
EyePoint Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 10/16/2018
EyePoint Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 6/29/2018
EyePoint Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 6/18/2018
EyePoint Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 3/21/2018
pSivida Corp.: Statement of changes in beneficial ownership of securities
4
Thursday, 6/29/2017
pSivida Corp.: Statement of changes in beneficial ownership of securities
3
Wednesday, 8/3/2016
pSivida Corp.: Initial statement of beneficial ownership of securities
4
Wednesday, 8/3/2016
pSivida Corp.: Statement of changes in beneficial ownership of securities
4
Thursday, 2/18/2016
LPATH, INC: Statement of changes in beneficial ownership of securities
4
Thursday, 6/18/2015
LPATH, INC: Statement of changes in beneficial ownership of securities
4
Wednesday, 2/11/2015
LPATH, INC: Statement of changes in beneficial ownership of securities
4
Wednesday, 2/12/2014
LPATH, INC: Statement of changes in beneficial ownership of securities
4
Thursday, 6/27/2013
LPATH, INC: Statement of changes in beneficial ownership of securities
3
Monday, 4/22/2013
LPATH, INC: Initial statement of beneficial ownership of securities
Show More